Findings from mice overexpressing DKK1 in bone cells confirmed defective hematopoietic stem cell transplant43, thus suggesting that DKK1 could lead to hematopoietic reprogramming towards immune suppression during tumor progression. The gene discussed is DKK1; the disease is neoplasm.